PHLDA1 and soft tissue sarcoma: PHLDA1 was found to be substantially associated with disease-free survival in patients with thyroid cancer, head and neck squamous cell carcinoma, pancreatic cancer, soft tissue sarcoma, bladder cancer, and endometrial cancer, as well as with overall survival in these patients.